Beta2-adrenergic receptors mediate the differential effects of catecholamines on cytokine production of PBMC

Journal of Interferon and Cytokine Research

Volumn 25, Issue 7, 2005, Pages 384-394

  Wahle, Matthias ^a   Neumann, R P ^b   Moritz, F ^a   Krause, A ^c   Buttgereit, F ^d   Baerwald, C G O ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Immanuel Hospital   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBODY; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CYCLIC AMP; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MITOGENIC AGENT; NORADRENALIN; PHYTOHEMAGGLUTININ; RADIOLIGAND; TETANUS TOXOID;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; BIOSYNTHESIS; CHEMISTRY; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; PHYSIOLOGY; T LYMPHOCYTE;

CYCLIC AMP; CYTOKINES; EPINEPHRINE; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, BETA-2; T-LYMPHOCYTES;

EID: 22644438346     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.384     Document Type: Article

References (62)

1. Panayi GS. Hormonal control of rheumatoid inflammation. Br. Med. Bull. 1995;51:462-471.
2. Harbuz MS. Chronic inflammatory stress. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 1999;13:555-565.
3. Felten DL. Direct innervation of lymphoid organs: substrate for neurotransmitter signaling of cells of the immune system. Neuropsychobiology 1993;28:110-112.
4. Felten SY, Olschowka J. Noradrenergic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic like contacts on lymphocytes in the splenic white pulp. J. Neurosci. Res. 1987;18:37-48.
5. Felten DL, Felten SY, Bellinger DL, Lorton D. Noradrenergic and peptidergic innervation of secondary lymphoid organs: role in experimental rheumatoid arthritis. Eur. J. Clin. Invest. 1992;22: 37-41.
6. Madden KS, Bellinger DL, Felten SY, Snyder E, Maida ME, Felten DL. Alterations in sympathetic innervation of thymus and spleen in aged mice. Mech. Ageing Dev. 1997;94:165-175.
7. Landmann RM, Burgisser E, Wesp M, Buhler FR. Beta-adrenergic receptors are different in subpopulations of human circulating lymphocytes. J. Recept. Res. 1984;4:37-50.
8. +) cells. J. Neuroimmunol. 1997;74:159-164.
9. Izeboud CA, Mocking JA, Monshouwer M, van Miert AS, Witkamp RF. Participation of beta-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. J. Recept. Signal Transduct. Res. 1999;19:191-202.
10. Davies AO, Lefkowitz RJ. In vitro desensitization of beta adrenergic receptors in human neutrophils. Attenuation by corticosteroids. J. Clin. Invest. 1983;71:565-571.
11. Radojcic T, Baird S, Darko D, Smith D, Bulloch K. Changes in beta-adrenergic receptor distribution on immunocytes during differentiation: an analysis of T cells and macrophages. J. Neurosci. Res. 1991;30:328-335.
12. Ader R, Felten D, Cohen N. Interactions between the brain and the immune system. Annu. Rev. Pharmacol. Toxicol. 1990;30:561-602.
13. Baerwald CG, Burmester GR, Krause A. Interactions of autonomic nervous, neuroendocrine, and immune systems in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 2000;26:841-857.
14. Böyum AS. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 1968;21(Suppl. 97):77-89.
15. Miltenyi S, Müller W, Weichel W, Radbruch A. High gradient magnetic cell separation with MACS. Cytometty 1990;11:231-238.
16. 2-adrenergic receptors. Br. J. Rheumatol. 1997;36:1262-1269.
17. Klausner RD, Donaldson JG, Lippincott-Schwartz J, Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol. 1992;116:1071-1080.
18. Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR, Maino VC. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995;86:1408-1419.
19. Baerwald C, Graefe C, von Wiehert P, Krause A. Decreased density of beta-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis. J. Rheumatol. 1992;19: 204-210.
20. Felten DL, Felten SY, Bellinger DL, Carlson SL, Ackerman KD, Madden KS, Olschowki JA, Livnat S. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol. Rev. 1987;100:225-260.
21. 2-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatic diseases. Eur. J. Clin. Invest. 1992;22(Suppl 1):42-46.
22. Scatchard G. The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci. 1949;51:660-672.
23. Sander B, Andersson J, Andersson U. Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol. Rev. 1991;119:65-93.
24. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 1995;184:39-51.
25. Heijnen CJ, Rouppe van der Voort C, Wulffraat N, van der Net J, Kuis W, Kavelaars A. Functional alphapadrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J. Neuroimmunol. 1996;71:223-226.
26. Rouppe van der Voort C, Kavelaars A, van de Pol M, Heijnen CJ. Noradrenaline induces phosphorylation of ERK-2 in human peripheral blood mononuclear cells after induction of alpha(1)-adrenergic receptors. J. Neuroimmunol. 2000;108:82-91.
27. 2-adrenoceptor subtype. Am. J. Respir. Cell Mol. Biol. 1998;19:400-407.
28. 2-adrenergic receptors on human alveolar macrophages. Am. Rev. Respir. Dis. 1989;139:552-555.
29. Kammer GM. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 1988;9:222-229.
30. Montminy M. Transcriptional regulation by cyclic AMP. Annu. Rev. Biochem. 1997;66:807-822.
31. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2001;2:599-609.
32. Andrade-Mena CE. Inhibition of gamma interferon synthesis by catecholamines. J. Neuroimmunol. 1997;76:10-14.
33. 2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 1997;100:1513-1519.
34. 2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action. J. Immunol. 1999;162:6278-6283.
35. Agarwal SK, Marshall GD, Jr. Beta-adrenergic modulation of human type-1/type-2 cytokine balance. J. Allergy Clin. Immunol. 2000;105:91-98.
36. Straub RH, Linde HJ, Männel DN, Schölmerich J, Falk W. A bacteria-induced switch of sympathetic effector mechanisms augments local inhibition of TNF-alpha and IL-6 secretion in the spleen. FASEB J. 2000;14:1380-1388.
37. Maisel AS, Fowler P, Rearden A, Motulsky HJ, Michel MC. A new method for isolation of human lymphocyte subsets reveals differential regulation of beta-adrenergic receptors by terbutaline treatment. Clin. Pharmacol. Ther. 1989;46:429-439.
38. Stiles GL, Caron MG, Lefkowitz RJ. Beta-adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol. Rev. 1984;64:661-743.
39. Xiao RP, Cheng H, Zhou YY, Kuschel M, Lakatta EG. Recent advances in cardiac beta(2)-adrenergic signal transduction. Circ. Res. 1999;85:1092-1100.
40. Slotkin TA, Auman JT, Seidler FJ. Ontogenesis of beta-adrenoceptor signaling: implications for perinatal physiology and for fetal effects of tocolytic drugs. J. Pharmacol. Exp. Ther. 2003;306: 1-7.
41. Halper JP, Mann JJ, Weksler ME, Bilezikian JP, Sweeney JA, Brown RP, Golbourne T. Beta-adrenergic receptors and cyclic AMP levels in intact human lymphocytes: effects of age and gender. Life Sci. 1984;35:855-863.
42. Huszar E, Herjavecz I, Debreczeni LA. The beta-adrenoceptors of lymphocytes in asthmatic patients treated with beta-agonists. Bull. Eur. Physiopathol. Respir. 1987;23(Suppl 10):115s-117s.
43. Farmer P, Pugin J. Beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 2000; 279:L675-682.
44. Hsueh YP, Lai MZ. c-Jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in T lymphocytes. J. Biol. Chem. 1995;270:18094-18098.
45. Gu C, Ma YC, Benjamin J, Littman D, Chao MV, Huang XY. Apoptotic signaling through the beta-adrenergic receptor. A new Gs effector pathway. J. Biol. Chem. 2000;275:20726-20733.
46. Borger P, Jonker GJ, Vellenga E, Postma DS, De Monchy JG, Kauffman HF. Allergen challenge primes for IL-5 mRNA production and abrogates beta-adrenergic function in peripheral blood T lymphocytes from asthmatics. Clin. Exp. Allergy 1999;29:933-940.
47. 2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. Cell. Immunol. 1994;158:182-194.
48. Leca G, Boumsell L, Fabbi M, Reinherz EL, Kanellopoulos JM. The sheep erythrocyte receptor and both alpha and beta chains of the human T-lymphocyte antigen receptor bind the mitogenic lectin (phytohaemagglutinin) from Phaseolus vulgaris. Scand. J. Immunol. 1986;23:535-544.
49. Kanellopoulos JM, De Petris S, Leca G, Crumpton MJ. The mitogenic lectin from Phaseolus vulgaris does not recognize the T3 antigen of human T lymphocytes. Eur. J. Immunol. 1985;15: 479-486.
50. Bartik MM, Bauman GP, Brooks WH, Roszman TL. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells. Cell. Immunol. 1994;158:116-130.
51. + T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 2001;53:487-525.
52. 2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J. Immunol. 1997;158:4200-4210.
53. 2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J. Immunol. 1997;159:4857-4867.
54. Cook-Mills JM, Cohen RL, Perlman RL, Chambers DA. Inhibition of lymphocyte activation by catecholamines: evidence for a non-classical mechanism of catecholamine action. Immunology 1995; 85:544-549.
55. Ben-Sasson SZ, Le Gros G, Conrad DH, Finkelman FD, Paul WE. IL-4 production by T cells from naive donors. IL-2 is required for IL-4 production. J. Immunol. 1990;145:1127-1136.
56. Straub RH, Herrmann M, Berkmiller G, et al. Neuronal regulation of interleukin 6 secretion in murine spleen: adrenergic and opioidergic control. J. Neurochem. 1997;68:1633-1639.
57. Newman WH, Castresana MR, Webb JG, Wang Z. Cyclic AMP inhibits production of interleukin-6 and migration in human vascular smooth muscle cells. J. Surg. Res. 2003;109:57-61.
58. Chen X, Dai JC, Greenfield EM. Termination of immediate-early gene expression after stimulation by parathyroid hormone or isoproterenol. Am. J. Physiol Cell Physiol. 2002;283:C1432-1440.
59. Mohamed-Ali V, Flower L, Sethi J, et al. Beta-adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 2001;86:5864-5869.
60. Bürger A, Benicke M, Deten A, Zimmer HG. Catecholamines stimulate interleukin-6 synthesis in rat cardiac fibroblasts. Am. J. Physiol. Heart Circ. Physiol. 2001;281:H14-21.
61. 2-adrenoceptor in endotoxin-stimulated renal macrophage cells. Kidney Int. 1999;56:839-849.
62. Parissis JT, Adamopoulos SN, Venetsanou KF, Karas SM, Kremastinos DT. Elevated plasma amylase levels in advanced chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy: correlation with circulating interleukin-6 activity. J. Interferon Cytokine Res. 2003;23:329-333.